Aprameya Engineering Peer Comparison
NSE: APRAMEYA
₹124.25
₹-1.75
(-1.39%)
As on 28-Aug-2026IST
Market cap
₹237 Cr
Revenue (TTM)
₹55 Cr
P/E Ratio
46.4
P/B Ratio
3.4
Div. Yield
0 %
Edit
| Aprameya Engineering | Poly Medicure | Nureca | QMS Medical | Alan Scott | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
237 | 17,553 | 316 | 294 | 209 |
Revenue (₹ Cr) |
55 | 1,997 | 153 | 183 | 34 |
Net Profit (₹ Cr) |
5.13 | 307.01 | 4.34 | 12.72 | -4.78 |
Net Margin (%) |
9.22 | 14.56 | 2.70 | 6.90 | -13.48 |
RoE (%) |
7.67 | 10.63 | 2.29 | 10.39 | -30.48 |
Price to Earnings |
46.37 | 55.71 | 72.90 | 26.98 | -- |
Price-To-Book |
3.41 | 5.52 | 1.72 | -- | 11.89 |
Income Statement (₹ Cr)
| Aprameya Engineering | Poly Medicure | Nureca | QMS Medical | Alan Scott | |
|---|---|---|---|---|---|
|
Operating Revenue
|
55.13 | 1,875.26 | 146.96 | -- | -- |
|
Total Income
|
55.62 | 2,002.19 | 155.06 | -- | -- |
|
Total Expenditure
|
44.60 | 1,436.66 | 146.78 | -- | -- |
|
EBITDA
|
10.54 | 438.59 | 0.18 | -- | -- |
|
Depreciation
|
0.09 | 115.52 | 2.02 | -- | -- |
|
EBIT
|
10.44 | 323.08 | -1.84 | -- | -- |
|
Interest
|
3.64 | 21.42 | 1.28 | -- | -- |
|
Other Income
|
0.49 | 126.93 | 8.10 | -- | -- |
|
Exceptional Items
|
-- | -6.80 | -- | -- | -- |
|
Profit before Tax
|
7.29 | 427.47 | 4.98 | -- | -- |
|
Provision for Tax
|
2.16 | 106.74 | 2.90 | -- | -- |
|
Profit after Tax
|
5.13 | 320.73 | 2.08 | -- | -- |
Liabilities (₹ Cr)
| Aprameya Engineering | Poly Medicure | Nureca | QMS Medical | Alan Scott | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
69.40 | 3,106.17 | 180.76 | -- | -- |
|
Minority Interest
|
0.18 | 43.07 | -- | -- | -- |
|
Non-Current Liabilities
|
1.26 | 120.16 | -0.92 | -- | -- |
|
Current Liabilities
|
10.50 | 666.53 | 13.78 | -- | -- |
|
Total Liabilities
|
82.27 | 3,951.60 | 196.16 | -- | -- |
Assets (₹ Cr)
| Aprameya Engineering | Poly Medicure | Nureca | QMS Medical | Alan Scott | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
8.03 | 1,903.19 | 78.94 | -- | -- |
|
Current Assets
|
73.30 | 2,032.74 | 114.68 | -- | -- |
|
Total Assets
|
82.27 | 3,951.60 | 196.16 | -- | -- |
|
Total Debt*
|
7.14 | 341.62 | 0.72 | -- | -- |
|
Net Current Assets
|
62.80 | 1,366.21 | 100.90 | -- | -- |
|
Contingent Liabilities
|
8.06 | 50.21 | 4.73 | -- | -- |
Cashflow (₹ Cr)
| Aprameya Engineering | Poly Medicure | Nureca | QMS Medical | Alan Scott | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
31.23 | 246.37 | 3.30 | -- | -- |
|
Cash Flow from Investing Activities
|
-4.45 | -225.38 | 14.49 | -- | -- |
|
Cash from Financing Activities
|
-26.66 | 20.15 | -19.56 | -- | -- |
|
Net Cash Inflow / Outflow
|
0.12 | 41.14 | -1.77 | -- | -- |
Ratios
Profitability Ratios
| Aprameya Engineering | Poly Medicure | Nureca | QMS Medical | Alan Scott | |
|---|---|---|---|---|---|
|
ROCE (%)
|
12.77 | 14.05 | 3.31 | -- | -- |
|
ROE (%)
|
7.67 | 10.94 | 1.11 | -- | -- |
|
ROA (%)
|
4.56 | 8.89 | 1.04 | -- | -- |
|
EBIT Margin (%)
|
19.99 | 30.16 | 5.63 | -- | -- |
|
Net Margin (%)
|
9.22 | 16.02 | 1.34 | -- | -- |
|
Cash Profit Margin (%)
|
9.46 | 23.12 | 2.57 | -- | -- |
Growth Ratios
| Aprameya Engineering | Poly Medicure | Nureca | QMS Medical | Alan Scott | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-59.37 | 12.30 | 34.02 | -- | -- |
|
EBIT Growth (%)
|
-55.90 | 3.80 | 69.11 | -- | -- |
|
Net Profit Growth (%)
|
-68.18 | -5.27 | 145.86 | -- | -- |
|
EPS Growth (%)
|
-68.34 | -4.88 | 157.91 | -- | -- |
|
Book Value Growth (%)
|
8.00 | 12.14 | -6.96 | -- | -- |
Valuation Ratios
| Aprameya Engineering | Poly Medicure | Nureca | QMS Medical | Alan Scott | |
|---|---|---|---|---|---|
|
Price / Earnings
|
76.00 | 37.47 | 94.46 | -- | -- |
|
Price / Book Value
|
5.59 | 3.90 | 1.09 | -- | -- |
|
Dividend Yield (%)
|
0.00 | 0.29 | 0.00 | -- | -- |
|
EV/EBITDA
|
35.29 | 21.79 | 18.84 | -- | -- |
|
Market Cap (₹ Cr)
|
387.75 | 12,069.92 | 196.67 | -- | -- |
Solvency Ratios
| Aprameya Engineering | Poly Medicure | Nureca | QMS Medical | Alan Scott | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.10 | 0.11 | 0.00 | -- | -- |
|
Short term debt to equity ratio
|
0.06 | 0.08 | 0.00 | -- | -- |
|
Current Ratio
|
6.98 | 3.05 | 8.32 | -- | -- |
|
Quick Ratio
|
6.73 | 2.40 | 4.88 | -- | -- |
|
Interest Coverage
|
3.00 | 20.96 | 4.88 | -- | -- |
Operating Efficiency Ratios
| Aprameya Engineering | Poly Medicure | Nureca | QMS Medical | Alan Scott | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
100.70 | 28.33 | 5.27 | -- | -- |
|
Asset Turnover
|
0.49 | 0.52 | 0.80 | -- | -- |
|
Receivable days
|
577.64 | 85.20 | 12.70 | -- | -- |
|
Inventory Days
|
32.62 | 69.58 | 100.27 | -- | -- |
|
Payable days
|
666.27 | 77.97 | 22.92 | -- | -- |
|
Cash Conversion Cycle
|
-56.01 | 76.82 | 90.04 | -- | -- |
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
